PPMI_57670, FCDI_11471

General

Cell Line

hPSCreg name CDIi079-A
Cite as:
CDIi079-A (RRID:CVCL_D5WQ)
Alternative name(s)
PPMI_57670, FCDI_11471
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CDIi057-A
(PPMI_56954, FCDI_11355)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi058-A
(FCDI_11362, PPMI_51755)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi061-A
(FCDI_11371, PPMI_55380)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi073-A
(PPMI_52400, FCDI_11460)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi074-A
(PPMI_54908, FCDI_11462)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi084-A
(FCDI_11483, PPMI_57292)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi024-A
(FCDI_11305, PPMI_51867)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi091-A
(FCDI_11498, PPMI_51714)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi092-A
(FCDI_11500, PPMI_56169)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi094-A
(FCDI_11508, PPMI_52517)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi096-A
(FCDI_11526, PPMI_57961)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi098-A
(FCDI_11545, PPMI_52932)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi035-A
(PPMI_51330, FCDI_11318)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi099-A
(FCDI_11546, PPMI_53518)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi036-A
(PPMI_42072, FCDI_11319)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi103-A
(FCDI_11571, PPMI_58182)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi044-A
(PPMI_50184, FCDI_11334)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi055-A
(FCDI_11349, PPMI_60003)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi059-A
(PPMI_52828, FCDI_11363)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi062-A
(FCDI_11436, PPMI_90456)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi075-A
(PPMI_54991, FCDI_11463)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi076-A
(PPMI_56680, FCDI_11465)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi081-A
(PPMI_57447, FCDI_11474)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi083-A
(PPMI_52524, FCDI_11478)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi086-A
(PPMI_18567, FCDI_11486)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi104-A
(FCDI_11578, PPMI_54048)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi043-A
(PPMI_54262, FCDI_11331)
Donor diseases:
Parkinson's Disease
prodromal period
CDIi046-A
(FCDI_11340, PPMI_56779)
Donor diseases:
Parkinson's Disease
prodromal period
Last update 17th April 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator FUJIFILM Cellular Dynamics, Inc. (CDI)
Owner The Michael J. Fox Foundation (MJFF)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA115473892
Cellosaurus CVCL_D5WQ, CVCL_D5WR, CVCL_D5WS

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 60-64

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Prodromal/ GBA N409S
Genetic variants
Synonyms
  • Parkinson Disease
  • Parkinson's disease
  • Parkinson's Disease

External Databases (Donor)

BioSamples SAMEA115473893

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: ppmi@michaeljfox.org
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink ppmi@michaeljfox.org
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? PPMI
Approval number 001
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? PPMI
Approval number 001
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A cell found predominately in the blood.
Age of donor (at collection) 60-64

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
LIN28
Yes
Undifferentiated cells were analyzed by proprietary assays approved by California Institute of Regenerative Medicine (CIRM) as described in the attached publication. Pluripotency of established iPSC cultures were tested by qPCR on bulk samples using 48 genes including standard pluripotency genes (listed above). Samples were assigned a passing score after analysis with a non-supervised classifier based on an appropriate sample set. (Novak, T. 2015. Drug Discovery World pp. 47-53.)
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal

Other Genotyping (Cell Line)